[PDF][PDF] Nanobody—A versatile tool for cancer diagnosis and therapeutics

M Liu, L Li, D Jin, Y Liu - Wiley Interdisciplinary Reviews …, 2021 - researchgate.net
In spite of the successful use of monoclonal antibodies (mAbs) in clinic for tumor treatment,
their applications are still hampered in therapeutic development due to limitations, such as …

Single Domain Antibody application in bacterial infection diagnosis and neutralization

Q Qin, H Liu, W He, Y Guo, J Zhang, J She… - Frontiers in …, 2022 - frontiersin.org
Increasing antibiotic resistance to bacterial infections causes a serious threat to human
health. Efficient detection and treatment strategies are the keys to preventing and reducing …

Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: A case report and revies of the literature

G Zhao, R Wei, L Feng, Y Wu, F He, M Xiao… - Cancer Immunology …, 2022 - Springer
We report successful clinical experience using anti-BCMA CAR-T combined with
lenalidomide in a patient who was refractory to a previous CAR-T treatment. The patient was …

Immunotherapy of multiple myeloma: promise and challenges

HN Abramson - ImmunoTargets and Therapy, 2021 - Taylor & Francis
Whereas the treatment of MM was dependent solely on alkylating agents and corticosteroids
during the prior three decades, the landscape of therapeutic measures to treat the disease …

Food-Borne Biotoxin Neutralization in Vivo by Nanobodies: Current Status and Prospects

ML Liu, XM Liang, MY Jin, HW Huang… - Journal of Agricultural …, 2024 - ACS Publications
Food-borne biotoxins from microbes, plants, or animals contaminate unclean, spoiled, and
rotten foods, posing significant health risks. Neutralizing such toxins is vital for human …

Long-term outcome after allogeneic stem cell transplantation in multiple myeloma

S Luoma, R Silvennoinen, A Rauhala… - Annals of …, 2021 - Springer
The role of allogeneic hematopoietic stem cell transplantation (allo-SCT) in multiple
myeloma is controversial. We analyzed the results of 205 patients transplanted in one center …

[HTML][HTML] A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy

Y Wang, Y Mei, Z Ao, Y Chen, Y Jiang, X Chen, R Qi… - Antiviral Research, 2022 - Elsevier
Sustainable viral suppression with hepatitis B surface antigen (HBsAg) loss is the new
treatment goal for chronic hepatitis B (CHB). The role of antibodies in therapies for persistent …

Nanobody-based food allergen surveillance: current status and prospects

Y Wang, S Wu, A Li, H Lv, X Ji, Y Hu… - Food Quality and …, 2024 - academic.oup.com
The incidence of food allergy increased in recent decades to drastically pose risk on
sensitive individuals to result in allergic symptoms from mild to severe detection methods …

Specific HLA alleles, paired with TCR V-and J-gene segment usage, link to distinct multiple myeloma survival rates

TI Huda, M Mihyu, EC Gozlan, MF Arndt… - Leukemia & …, 2021 - Taylor & Francis
Multiple myeloma (MM) immunogenomics studies related to T-cell characterizations and
involving large patient sets have been lacking, particularly in comparison to solid tumor …

Development and Characterization of a Novel Single-Chain Antibody Against B-Cell Activating Factor

R Mardani-Jouneghani, S Irani… - Molecular …, 2023 - Springer
As a member of the tumor necrosis factor (TNF) superfamily, the B-cell activating factor
(BAFF) plays a crucial role in B-cell survival and differentiation. Overexpression of this …